Jin Yang Pharmaceutical Co., Ltd. announced that it expects to receive KRW 16 billion in funding from Shinhan Investment Corp., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, HisStory Investment Management, Investment arm and other investors
November 23, 2021
Share
Jin Yang Pharmaceutical Co., Ltd. announced that it will issue series 1 unregistered non-guaranteed private convertible bonds for gross proceeds of KRW 16,000,000,000,000 on November 24, 2021. The transaction will include participation from Shinhan Investment Corp., Investment Arm for KRW 1,000,000,000, Mirae Asset Daewoo Co., Ltd., Investment Arm for KRW 1,000,000,000, HisStory Investment Management, Investment arm for KRW 1,000,000,000, Gongju Heo for KRW 2,000,000,000, Youngjin Kwon for KRW 1,500,000,000 and other investors. The bonds bear surface interest rate and maturity rate of 0% and will mature on November 26, 2026. The bonds are 100% convertible into 2,399,520 shares representing 16.66% stake at a conversion price of KRW 6,668 per share from November 26, 2022 to October 26, 2026. The subscription date and expected date of payment is November 26, 2021. The transaction is approved by the board of directors of the company.
JIN YANG PHARMACEUTICAL CO., LTD is a Korea-based company mainly engaged in the manufacturing and distributing of medicine and medicine supplies. The Companyâs products consist of drugs for the circulation systems, digestive organs and the central nervous systems, antibiotics, metabolic drugs, and others including antihistaminic agents, anti-inflammatory analgesic drugs, antimicrobials, muscle relaxants, psychotropic agents, high blood pressure medicines, diabetes medicines, injection medicines, skin disease medicines, nutritional supplements, anemia medicines, dental care drugs, ophthalmology care drugs and others. The Company distributes its products within domestic market and to overseas markets.
Jin Yang Pharmaceutical Co., Ltd. announced that it expects to receive KRW 16 billion in funding from Shinhan Investment Corp., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, HisStory Investment Management, Investment arm and other investors